2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol
C26H35ClN2O2 — CID 139676959
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol
2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol (PubChem CID 139676959) has the molecular formula C26H35ClN2O2 and a molecular weight of 443.03 g/mol. Its IUPAC name is 2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol.
Molecular Properties
| Compound Name | 2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol |
|---|---|
| PubChem CID | 139676959 |
| Molecular Formula | C26H35ClN2O2 |
| Molecular Weight | 443.03 g/mol |
| Exact Mass | 442.24 |
| IUPAC Name | 2-[2-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]ethyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol |
| SMILES | Cc1c(C)c2c(c(C)c1O)CCC(C)(CCN1CCN(Cc3ccccc3Cl)CC1)O2 |
| InChI | InChI=1S/C26H35ClN2O2/c1-18-19(2)25-22(20(3)24(18)30)9-10-26(4,31-25)11-12-28-13-15-29(16-14-28)17-21-7-5-6-8-23(21)27/h5-8,30H,9-17H2,1-4H3 |
| InChIKey | FQCQMUPJXJFWHU-UHFFFAOYSA-N |
| XLogP | 5.26 |
| TPSA | 35.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 443.03 |
| LogP ≤ 5 | 5.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139676959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.